AIMC Topic: Cyclin-Dependent Kinase Inhibitor p16

Clear Filters Showing 11 to 13 of 13 articles

Response to "Medical Statistics Unlock the Gateway to Further Research: Using Deep Learning to Predict CDKN2A/B Homozygous Deletion in Isocitrate Dehydrogenase-Mutant Astrocytoma".

Korean journal of radiology Dec 1, 2023
Humans Public Health Deep Learning Cyclin-Dependent Kinase Inhibitor p16 Isocitrate Dehydrogenase Homozygote Astrocytoma Sequence Deletion
View on PubMed DOI

Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinoma.

The Journal of clinical investigation Apr 15, 2021
BACKGROUNDPatients with p16+ oropharyngeal squamous cell carcinoma (OPSCC) are potentially cured with definitive treatment. However, there are currently no reliable biomarkers of treatment failure for p16+ OPSCC. Pathologist-based visual assessment o...
Humans Female Aged Survival Rate Biomarkers, Tumor Male Middle Aged Deep Learning Image Processing, Computer-Assisted Squamous Cell Carcinoma of Head and Neck Head and Neck Neoplasms Follow-Up Studies Cyclin-Dependent Kinase Inhibitor p16 Disease-Free Survival
View on PubMed DOI

[Role of high mobility group protein B1 in 
IL-1α-induced endothelial cell senescence].

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences Dec 28, 2017
To explore the effect of interleukin-1α (IL-1α) on the senescence of human umbilical vein endothelial cells (HUVECs) and the function of high mobility group protein 1 (HMGB1).
 Methods: HUVECs were randomly divided into a control group, a IL-1α group...
Humans RNA, Messenger Cyclin-Dependent Kinase Inhibitor p21 Cyclin-Dependent Kinase Inhibitor p16 HMGB1 Protein Human Umbilical Vein Endothelial Cells Sirtuin 1 Cellular Senescence Tumor Suppressor Protein p53 beta-Galactosidase Random Allocation Interleukin-1alpha
View on PubMed DOI
Popular Topics
Recent Journals